-
Product Insights
Artificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Artificial Pancreas Pipeline Market Report Overview The artificial pancreas aids people in controlling their blood glucose level or diabetes, primarily type 1, automatically by continuously providing the substitute endocrine functionality of a healthy pancreas. The artificial pancreas pipeline market research report provides comprehensive information about the products with their comparative segment-wise analysis at various stages of development. The report also covers the regional and country-wise artificial pancreas clinical trials outlook. The regulatory paths followed for conducting the artificial pancreas pipeline...
-
Product Insights
Reproductive Health Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Reproductive Health Devices Pipeline Market Report Overview Endometrial ablation devices, female sterilization devices, reversible contraceptive devices, and assisted reproductive technology devices are the main categories of reproductive health devices. The reproductive health devices pipeline report provides comprehensive information about the main products with their comparative segment-wise analysis at various stages of development. The report also covers the regional and country-wise reproductive health devices clinical trials outlook. The regulatory paths followed for conducting the reproductive health devices pipeline research are also...
-
Product Insights
NewCongenital Ichthyosis – Drugs In Development, 2024
Empower your strategies with our Congenital Ichthyosis – Drugs In Development, 2024 report and make more profitable business decisions. Congenital ichthyosis is a collective name for a group of monogenetic disorders of cornification, sometimes associated with systemic symptoms. There may be an abnormal quality or quantity of scale produced, abnormal thickness of stratum corneum or abnormal keratinocyte kinetics, often associated with skin inflammation. HI is inherited in an autosomal recessive fashion and arises secondary to mutations in the ABCA12 gene 1–3....
-
Product Insights
NewPeritonitis – Drugs In Development, 2024
Empower your strategies with our Peritonitis – Drugs In Development, 2024 report and make more profitable business decisions. Peritonitis is inflammation of the peritoneum. There are two types of peritonitis. Spontaneous bacterial peritonitis (SBP) is the result of an infection of the fluid in peritoneal cavity. Secondary peritonitis is usually due to an infection that has spread from the digestive tract. Symptoms include abdominal bloating, nausea and vomiting, diarrhea, fatigue, fever, and chills. Treatment includes antibiotics. The Peritonitis drugs in development...
-
Product Insights
NewInherited Skin Disorders – Drugs In Development, 2024
Empower your strategies with our Inherited Skin Disorders – Drugs In Development, 2024 report and make more profitable business decisions. Inherited skin disorders encompass a diverse group of genetic conditions affecting the skin's structure, function, or development. These disorders can manifest as a range of symptoms, including abnormalities in pigmentation, texture, or the presence of certain growths or lesions. Examples of inherited skin disorders include epidermolysis bullosa, ichthyosis, and albinism. These conditions often result from mutations in specific genes responsible for...
-
Product Insights
NewCryopyrin-Associated Periodic Syndromes – Drugs In Development, 2024
Empower your strategies with our Cryopyrin-Associated Periodic Syndromes – Drugs In Development, 2024 report and make more profitable business decisions. cryopyrin-associated periodic syndromes are a group of autoimmune diseases caused by a defect in the cryopyrin protein. Genetic mutations on the NLRP3 gene result in overproduction of interleukin 1 beta due to excessive inflammasome activation. This is generally seen in children and is a rare form. It includes Neonatal Onset Multisystem Inflammatory Disease (NOMID), Muckle-Wells Syndrome (MWS) and Familial Cold Autoinflammatory...
-
Product Insights
NewCorneal Dystrophy – Drugs In Development, 2024
Empower your strategies with our Corneal Dystrophy – Drugs In Development, 2024 report and make more profitable business decisions. Corneal dystrophy (CD) is defined as a collection of rare hereditary non-inflammatory disorders of abnormal deposition of substances in the cornea. The material may cause the cornea to lose its transparency and can cause loss of vision or blurred vision. Corneal dystrophies can appear at any age and men and women are equally affected by most corneal dystrophies. The symptoms of corneal...
-
Product Insights
NewTyphoid Fever – Drugs In Development, 2024
Empower your strategies with our Typhoid Fever – Drugs In Development, 2024 report and make more profitable business decisions. Typhoid fever is an infection that causes diarrhea and a rash. It is most commonly due to a type of bacterium called Salmonella typhi. Symptoms include abdominal tenderness, agitation, chills, delirium, hallucinations, severe fatigue, and weakness. Treatment includes antibiotics and supportive therapy. The Typhoid Fever drugs in development market research report provide comprehensive information on the therapeutics under development for Typhoid Fever,...
-
Product Insights
NewFuchs Endothelial Corneal Dystrophy (FECD) – Drugs In Development, 2024
Empower your strategies with our Fuchs Endothelial Corneal Dystrophy (FECD) – Drugs In Development, 2024 report and make more profitable business decisions. Fuchs endothelial corneal dystrophy (FECD) is characterized by progressive loss of corneal endothelial cells, thickening of Descement's membrane and deposition of extracellular matrix in the form of guttae. When the number of endothelial cells becomes critically low, the cornea swells and causes loss of vision. It affects the thin layer of cells that line the back part of the...